Searched for
PIRAMAL PHARMA Q2 RESULTS
Stocks in news: Waaree Energies, Kotak Bank, HDFC Bank, Strides Pharma, Persistent SystemsIndian markets showed volatility, ending nearly flat despite positive signals. Analysts note Nifty faces resistance from key moving average...
FIFA World Cup 2026 Today Match Schedule (June 28) Indian Time (IST): Full match list, fixtures, India time (IST), venues and standings scenarioFIFA World Cup 2026 match schedule for 28th June: The FIFA World Cup 2026 group stage heats up on June 28th with six crucial matches across...
Q1 earnings preview: Here’s what Nomura expects from Nestle, Titan, other consumer majors’ June quarter resultsNomura expects consumer staples to deliver a strong start to FY27, forecasting double-digit sales growth for several companies in the June ...
Pharma, power & mid-sized banks: Where Mayuresh Joshi is putting money to work right nowIndian markets are showing signs of recovery as geopolitical tensions ease, paving the way for a stronger earnings outlook in the second ha...
Affordable housing finance firms likely to regain growth in FY27, but macro risks loom: KotakAffordable housing finance companies are poised for a growth rebound from FY27, according to Kotak Institutional Securities. After a subdue...
India's office market remains cautious despite resilient demand and selective rental gains: ReportIndia's office market saw demand outpace new supply in Q2 FY26, leading to modest rent increases in active areas. Despite a cautious overal...
Buy, Sell or Hold: Goldman Sachs maintains sell on Bharat Dynamics; HDFC Securities maintains buy on IndiaMART InterMESHBrokerages remain divided on two stocks. Goldman Sachs retained its 'Sell' rating on Bharat Dynamics, raising the target price marginally t...
Nominal GDP growth could fuel largecap recovery; pharma, auto ancillaries remain preferred bets: Shreyash DevalkarIndian stock markets are defying foreign investor caution, driven by resilient June-quarter earnings. Companies are navigating geopolitical...
Ahead of Market: 10 things that will decide stock market action on WednesdaySensex and Nifty plunged over 1% on Tuesday amid global market weakness, IT sector losses, a weaker rupee and fresh foreign fund outflows. ...
Honasa Consumer enters nutraceuticals segment; to acquires 58 pc stake in Fluence PharmaHonasa Consumer, parent of Mamaearth, is acquiring a 58% stake in nutraceuticals firm Fluence Pharma for Rs 135 crore, marking its entry in...
PSU banks lose gold loan sourcing share as private banks, NBFCs gain traction: ReportPublic sector banks are losing ground in the gold loan market to private lenders and NBFCs, which offer faster service and wider reach. Whi...
Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...
Meesho shares rise 2% as Citi initiates coverage with Buy rating. Here's whyInternational brokerage Citi initiated coverage on Meesho with a 'Buy' rating, setting a target price of Rs 210 and anticipating a 23% upsi...
Bharat Electronics shares in focus after defence PSU wins orders worth Rs 1,081 croreBharat Electronics shares are in focus following a significant Rs 1,081 crore order win, adding to previous gains. The defence PSU reported...
Sun Pharma adds Innovcare to its fold in Rs 271.2 crore all-cash transactionIndia's largest drugmaker, Sun Pharma, is set to acquire Mumbai-based Innovcare Lifesciences for approximately $28.7 million in an all-cash...
Jio IPO: Akash, Isha and Anant Ambani to lead IPO process, says Mukesh AmbaniReliance Industries Chairman Mukesh Ambani announced that the board has approved the draft prospectus for the much-awaited IPO of Jio Platf...
ICICI Prudential AMC shares fall 2% as IPO lock-in expiry frees up Rs 1.2 lakh crore stake for tradeICICI Prudential AMC shares dropped 2% to Rs 513 as 34.4 crore shares became eligible for trade post IPO lock-in expiry. The company's stoc...
Buy, Sell or Hold: Morgan Stanley raises target price on NYKAA; Elara Capital maintains buy on Devyani InternationalBrokerage views on Indian equities are mixed as Morgan Stanley raises Nykaa's target price on ambitious FY30 growth plans. Conversely, conc...
AP Intermediate Supplementary Results 2026 out at resultsbie. ap. gov. in, BIEAP 1st, 2nd year results at bie. ap. gov. inresultsbie. ap. gov. in AP Inter Supply Results 2026 Released: The Board of Intermediate Education, Andhra Pradesh has released the AP Inte...
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsFrom a macro perspective, it is clearly a good time to be bullish. But as valuations remain high in parts of the market despite the recent ...